{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:24:07Z","timestamp":1779888247165,"version":"3.53.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1038\/leu.2013.272","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T07:47:50Z","timestamp":1379576870000},"page":"419-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy"],"prefix":"10.1038","volume":"28","author":[{"given":"S","family":"Koschmieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Berkemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Volpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wieacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Silling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W E","family":"Berdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,19]]},"reference":[{"key":"BFleu2013272_CR1","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1182\/blood-2006-04-014514","volume":"108","author":"T Burmeister","year":"2006","unstructured":"Burmeister T, Gokbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S . NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood 2006; 108: 3556\u20133559.","journal-title":"Blood"},{"key":"BFleu2013272_CR2","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"},{"key":"BFleu2013272_CR3","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003; 17: 2474\u20132486.","journal-title":"Leukemia"},{"key":"BFleu2013272_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/leu.2008.278","volume":"23","author":"C Graux","year":"2009","unstructured":"Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison CJ, Mugneret F et al. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia 2009; 23: 125\u2013133.","journal-title":"Leukemia"},{"key":"BFleu2013272_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/leu.2008.318","volume":"23","author":"W Deenik","year":"2009","unstructured":"Deenik W, Beverloo HB, van der Poel-van de Luytgaarde SC, Wattel MM, van Esser JW, Valk PJ et al. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia. Leukemia 2009; 23: 627\u2013629.","journal-title":"Leukemia"},{"key":"BFleu2013272_CR6","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.leukres.2011.03.025","volume":"35","author":"S Clarke","year":"2011","unstructured":"Clarke S, O\u2019Reilly J, Romeo G, Cooney J . NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse. Leuk Res 2011; 35: e131\u2013e133.","journal-title":"Leuk Res"},{"key":"BFleu2013272_CR7","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/sj.leu.2403877","volume":"19","author":"K Stergianou","year":"2005","unstructured":"Stergianou K, Fox C, Russell NH . Fusion of NUP214 to ABL1 on amplified episomes in T-ALL\u2014implications for treatment. Leukemia 2005; 19: 1680\u20131681.","journal-title":"Leukemia"},{"key":"BFleu2013272_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/pbc.23327","volume":"59","author":"O Crombet","year":"2012","unstructured":"Crombet O, Lastrapes K, Zieske A, Morales-Arias J . Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification. Pediatr Blood Cancer 2012; 59: 333\u2013334.","journal-title":"Pediatr Blood Cancer"},{"key":"BFleu2013272_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ng1425","volume":"36","author":"C Graux","year":"2004","unstructured":"Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084\u20131089.","journal-title":"Nat Genet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2013272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:13:38Z","timestamp":1648739618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2013272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["BFleu2013272"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.272","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]},"assertion":[{"value":"19 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}